CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 875 of 2003 entries

View as:

Improving Access to Care: Testing an Integrated Care Mobile Health Intervention

Phase: N/A Priority: Normal

NCT ID: NCT03780088 Org: User:

Start: 01/16/19 End: 04/15/21 Due: 04/15/22

Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis

Phase: N/A Priority: Normal

NCT ID: NCT00655239 Org: User:

Start: 06/30/08 End: 05/31/16 Due: 05/31/17

Molecular Profiling for Individualized Treatment Plan for DIPG

Phase: N/A Priority: Normal

NCT ID: NCT02274987 Org: User:

Start: 09/16/14 End: 02/24/19 Due: 02/24/20

Pharmacokinetics Distribution of Raltegravir by PET/MR

Phase: N/A Priority: Normal

NCT ID: NCT03174977 Org: User:

Start: 04/01/18 End: 01/01/25 Due: 01/01/26

Innate Immunity in Ozone-induced Airway Inflammation in COPD

Phase: N/A Priority: Normal

NCT ID: NCT04669743 Org: User:

Start: 04/07/16 End: 10/31/24 Due: 10/31/25

Peripheral Nerve Blocks for Major Lower Extremity Amputations

Phase: N/A Priority: Normal

NCT ID: NCT03174782 Org: User:

Start: 01/01/18 End: 04/27/21 Due: 04/27/22

Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding

Phase: N/A Priority: Normal

NCT ID: NCT05899413 Org: User:

Start: 02/17/24 End: 07/31/24 Due: 07/31/25

Ahmed Glaucoma Valve Surgery With Mitomycin-C

Phase: N/A Priority: Normal

NCT ID: NCT02805257 Org: User:

Start: 06/30/16 End: 03/31/20 Due: 03/31/21

Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model

Phase: N/A Priority: Normal

NCT ID: NCT02451345 Org: User:

Start: 03/25/15 End: 04/30/20 Due: 04/30/21

Smoking Treatment in HIV Clinical Care Settings

Phase: N/A Priority: Normal

NCT ID: NCT00297453 Org: User:

Start: 01/31/06 End: 01/31/11 Due: 01/31/12

Hypoglycemia Prediction Model

Phase: N/A Priority: Normal

NCT ID: NCT03006510 Org: User:

Start: 01/31/17 End: 06/01/18 Due: 06/01/19

Paleolithic Diets vs T2D and Improvements in the Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00548782 Org: User:

Start: 09/30/07 End: 09/30/16 Due: 09/30/17

Cultural Adaptation of Drug Treatment for DJJ Youth

Phase: N/A Priority: Normal

NCT ID: NCT06003725 Org: User:

Start: 05/15/24 End: 05/30/27 Due: 05/30/28

Azithromycin for Child Survival in Niger II

Phase: N/A Priority: Normal

NCT ID: NCT06358872 Org: User:

Start: 04/29/24 End: 04/29/28 Due: 04/29/29

Liberation From Acute Dialysis

Phase: N/A Priority: Normal

NCT ID: NCT04218370 Org: User:

Start: 01/23/20 End: 06/30/25 Due: 06/30/26

Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women

Phase: N/A Priority: Normal

NCT ID: NCT06953310 Org: User:

Start: 05/20/25 End: 01/31/28 Due: 01/31/29

Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT04061590 Org: User:

Start: 05/29/20 End: 08/31/23 Due: 08/31/24

The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy

Phase: N/A Priority: Normal

NCT ID: NCT03582891 Org: User:

Start: 10/01/18 End: 03/31/28 Due: 03/31/29

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT04201106 Org: User:

Start: 05/14/20 End: 12/30/32 Due: 12/30/33

Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1

Phase: N/A Priority: Normal

NCT ID: NCT04602806 Org: User:

Start: 06/01/21 End: 04/09/30 Due: 04/09/31

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

Phase: N/A Priority: Normal

NCT ID: NCT00804128 Org: User:

Start: 10/01/08 End: 01/05/24 Due: 01/05/25

Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum

Phase: N/A Priority: Normal

NCT ID: NCT00689910 Org: User:

Start: 02/29/08 End: - Due: -

Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso

Phase: N/A Priority: Normal

NCT ID: NCT00845533 Org: User:

Start: 08/31/07 End: 01/31/09 Due: 01/31/10

Correction of Psoriatic T Cell Signatures by Deucravacitinib

Phase: N/A Priority: Normal

NCT ID: NCT05858645 Org: User:

Start: 10/01/23 End: 06/30/26 Due: 06/30/27

Virtual Reality- Working Memory Retraining

Phase: N/A Priority: Normal

NCT ID: NCT03786276 Org: User:

Start: 02/01/19 End: 03/31/20 Due: 03/31/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Improving Access to Care: Testing an Integrated Care Mobile Health Intervention	NCT03780088	University of California, San Francisco	user2@example.com	None	2019-01-16	2021-04-15	2022-04-15	-	-	2025-07-14
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis	NCT00655239	University of California, San Francisco	user2@example.com	None	2008-06-30	2016-05-31	2017-05-31	-	-	2025-07-14
Molecular Profiling for Individualized Treatment Plan for DIPG	NCT02274987	University of California, San Francisco	user2@example.com	None	2014-09-16	2019-02-24	2020-02-24	-	-	2025-07-14
Pharmacokinetics Distribution of Raltegravir by PET/MR	NCT03174977	University of California, San Francisco	user2@example.com	None	2018-04-01	2025-01-01	2026-01-01	-	-	2025-07-14
Innate Immunity in Ozone-induced Airway Inflammation in COPD	NCT04669743	University of California, San Francisco	user2@example.com	None	2016-04-07	2024-10-31	2025-10-31	-	-	2025-07-14
Peripheral Nerve Blocks for Major Lower Extremity Amputations	NCT03174782	University of California, San Francisco	user2@example.com	None	2018-01-01	2021-04-27	2022-04-27	-	-	2025-07-14
Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding	NCT05899413	University of California, San Francisco	user2@example.com	None	2024-02-17	2024-07-31	2025-07-31	-	-	2025-07-14
Ahmed Glaucoma Valve Surgery With Mitomycin-C	NCT02805257	University of California, San Francisco	user2@example.com	None	2016-06-30	2020-03-31	2021-03-31	-	-	2025-07-14
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model	NCT02451345	University of California, San Francisco	user2@example.com	None	2015-03-25	2020-04-30	2021-04-30	-	-	2025-07-14
Smoking Treatment in HIV Clinical Care Settings	NCT00297453	University of California, San Francisco	user2@example.com	None	2006-01-31	2011-01-31	2012-01-31	-	-	2025-07-14
Hypoglycemia Prediction Model	NCT03006510	University of California, San Francisco	user2@example.com	None	2017-01-31	2018-06-01	2019-06-01	-	-	2025-07-14
Paleolithic Diets vs T2D and Improvements in the Metabolic Syndrome	NCT00548782	University of California, San Francisco	user2@example.com	None	2007-09-30	2016-09-30	2017-09-30	-	-	2025-07-14
Cultural Adaptation of Drug Treatment for DJJ Youth	NCT06003725	University of California, San Francisco	user2@example.com	None	2024-05-15	2027-05-30	2028-05-30	-	-	2025-07-14
Azithromycin for Child Survival in Niger II	NCT06358872	University of California, San Francisco	user2@example.com	None	2024-04-29	2028-04-29	2029-04-29	-	-	2025-07-14
Liberation From Acute Dialysis	NCT04218370	University of California, San Francisco	user2@example.com	None	2020-01-23	2025-06-30	2026-06-30	-	-	2025-07-14
Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women	NCT06953310	University of California, San Francisco	user2@example.com	None	2025-05-20	2028-01-31	2029-01-31	-	-	2025-07-14
Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer	NCT04061590	University of California, San Francisco	user2@example.com	None	2020-05-29	2023-08-31	2024-08-31	-	-	2025-07-14
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy	NCT03582891	University of California, San Francisco	user2@example.com	None	2018-10-01	2028-03-31	2029-03-31	-	-	2025-07-14
A Neuroimaging Study of Open-label Placebo in Depressed Adolescents	NCT04201106	University of California, San Francisco	user2@example.com	None	2020-05-14	2032-12-30	2033-12-30	-	-	2025-07-14
Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1	NCT04602806	University of California, San Francisco	user2@example.com	None	2021-06-01	2030-04-09	2031-04-09	-	-	2025-07-14
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)	NCT00804128	University of California, San Francisco	user2@example.com	None	2008-10-01	2024-01-05	2025-01-05	-	-	2025-07-14
Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum	NCT00689910	University of California, San Francisco	user2@example.com	None	2008-02-29	-	-	-	-	2025-07-14
Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso	NCT00845533	University of California, San Francisco	user2@example.com	None	2007-08-31	2009-01-31	2010-01-31	-	-	2025-07-14
Correction of Psoriatic T Cell Signatures by Deucravacitinib	NCT05858645	University of California, San Francisco	user2@example.com	None	2023-10-01	2026-06-30	2027-06-30	-	-	2025-07-14
Virtual Reality- Working Memory Retraining	NCT03786276	University of California, San Francisco	user2@example.com	None	2019-02-01	2020-03-31	2021-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance